Evidence map›Paper›PMID 41719450›Full record

ArticleBlood advances2026

Sickle cell vaso-occlusive episodes correlate with the magnetic heterogeneity of red blood cells.

Jacob Strayer, Xian Wu, Hyeon Choe, Poornima Ramesh Iyer, Jenifer Gómez-Pastora, William Moorman, Joseph Cefaratti, Alec West, Jacob Doon-Ralls, Kristina Landes and 6 more

Abstract read
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jacob StrayerWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH.ORCID 0000-0002-0808-3301
Xian WuWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH.
Hyeon ChoeWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH.ORCID 0009-0000-3618-0750
Poornima Ramesh IyerWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH.ORCID 0009-0009-0527-6202
Jenifer Gómez-PastoraDepartment of Chemical Engineering, Texas Tech University, Lubbock, TX.
William MoormanWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH.
Joseph CefarattiWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH.
Alec WestDepartment of Biology, College of Arts and Sciences, The Ohio State University, Columbus, OH.
Jacob Doon-RallsWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH.
Kristina LandesBenign Hematology Team, Wexner Medical Center, The Ohio State University, Columbus, OH.
Sherraine Della-MorettaBenign Hematology Team, Wexner Medical Center, The Ohio State University, Columbus, OH.
Andre F PalmerWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH.
Maciej ZborowskiDepartment of Biomedical Engineering, Cleveland Clinic, Cleveland, OH.
Paul W BuehlerCenter for Blood Oxygen Transport and Hemostasis, Department of Pediatrics, School of Medicine, University of Maryland, Baltimore, MD.
Jeffrey J ChalmersWilliam G. Lowrie Department of Chemical and Biomolecular Engineering, The Ohio State University, Columbus, OH.
Payal C DesaiLevine Cancer Institute, Atrium Health, Wake Forest University School of Medicine, Charlotte, NC.ORCID 0000-0003-1038-2500

Funding

Fractionation of Aged RBCs Based on Hemoglobin ContentR01HL131720 · NHLBI · OHIO STATE UNIVERSITY · PI CHALMERS, JEFFREY JOHN, PALMER, ANDRE FRANCIS · 2017 to 2020
$2.7M
Fractionation of RBCs via label-free magnetophoresis using novel additive-manufactured devicesR15HL181720 · NHLBI · TEXAS TECH UNIVERSITY · PI GOMEZ PASTORA, JENIFER · 2025 to 2025
$588k
Development of single cell magnetophoresis to analyze and isolate glioma cancer stem cellsR21CA250118 · NCI · OHIO STATE UNIVERSITY · PI CHALMERS, JEFFREY JOHN, VENERE, MONICA · 2020 to 2021
$385k
Sickle cell disease severity prediction from the magnetic signature and hemoglobin content of blood cellsR03AI188351 · NIAID · TEXAS TECH UNIVERSITY · PI GOMEZ PASTORA, JENIFER · 2025 to 2025
$150k
NCI NIH HHS R21 CA250118NHLBI NIH HHS R01 HL131720NHLBI NIH HHS R15 HL181720NIAID NIH HHS R03 AI188351
6 · The paper itself

Abstract

abstractSickle cell disease (SCD) is a complex condition that results in low oxygen affinity and oxidative damage within red blood cells (RBCs), which contributes to serious complications such as vaso-occlusive episodes (VOEs). Given the well-established theoretical and experimental evidence that oxygenated hemoglobin is diamagnetic, whereas deoxygenated hemoglobin and methemoglobin are paramagnetic, this study aims to investigate whether RBCs from patients with SCD exhibit progressively increased magnetic susceptibility in correlation with disease severity. In this study, we employed cell tracking velocimetry (CTV) to perform single-cell analysis of RBC magnetic properties under both oxygenated and deoxygenated states. CTV quantifies the oxygen saturation of each cell by measuring their magnetically induced cell velocities in conjunction with known cell properties. Subsequent statistical analysis revealed that although the mean oxygen saturation of the RBCs from patients with SCD did not differ significantly from that of healthy donors, the magnetic velocities at the 1st and 99th percentile of RBC samples from patients with SCD were significantly reduced and elevated, respectively. These elevated and reduced velocities correlate directly to the magnetic susceptibility of the cell, which corresponds to the hemoglobin state. Moreover, we identified a correlation (P< .01) between magnetic heterogeneity in the top and bottom 1% and pain severity, particularly in patients with SCD experiencing acute VOEs. This study underscores the potential of RBC magnetic properties as biophysical markers for identifying the pain severity in patients with SCD and opening avenues for personalized therapeutic interventions.

Indexed as

Anemia, Sickle CellErythrocytesAdultCell TrackingFemaleHumansMaleVaso-Occlusive Crises

Identifiers

PMID41719450
PMCPMC13122802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.